Sleep Disturbances as a Non-traditional Risk Factor in CKD-Actigraphy

Completed

Conditions studied: Chronic Kidney Disease, Sleep Loss

In brief

To test if usual at home night time sleep duration as measured with activity monitors and questionnaires will predict changes in kidney function as measured by kidney filtration rate and of cardiovascular function as measured by C-reactive protein in the blood. The study will explore the role of decreased sleep time or decreased sleep quality as a non-traditional risk factor for the progression of CKD and for the development of cardiovascular disease in CKD.

Key facts

Study ID

NCT00817674

Run by

University of Chicago

People needed

353

Starts

2007-11-01

Expected to finish

2010-10-01

Last updated by the study team

2013-09-05

Who can join

Age: 21 and older, up to 74. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Mild to Moderate CKD
• Healthy controls age and gender matched to CKD subjects
• Regular bedtimes of at least 6h/night, sedentary lifestyle

You may not qualify if…

• Diabetes
• Current or previous dialysis for more than 1 month
• Uncontrolled hypertension
• Heart failure
• Liver disease
• HIV
• Hemoglobin < 10.5 g/dl
• Treatment with EProcrit, Epogen, or Aranesp
• Bone or organ transplant,
• Use of immunosuppressive drugs within past 6 months
• Current oral contraceptive use
• Current pregnancy
• Chemotherapy for malignancy within past 2 years

Where it is running

• The University of Chicago — Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.